Insider Transactions in Q4 2020 at Cvs Health Corp (CVS)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2020
|
Karen S Lynch President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,779
-11.93%
|
$881,751
$69.63 P/Share
|
|
Dec 02
2020
|
Jonathan E. Mayhew EVP - Transformation |
SELL
Payment of exercise price or tax liability
|
Direct |
926
-11.9%
|
$63,894
$69.63 P/Share
|
|
Nov 30
2020
|
Neela Montgomery EVP and Pres., Pharmacy/Retail |
BUY
Grant, award, or other acquisition
|
Direct |
29,502
+50.0%
|
$1,976,634
$67.79 P/Share
|
|
Nov 18
2020
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,865
+1.54%
|
$123,090
$66.35 P/Share
|
|
Nov 18
2020
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,752
+50.0%
|
$115,632
$66.35 P/Share
|
|
Nov 18
2020
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,836
+4.98%
|
$121,176
$66.35 P/Share
|
|
Nov 18
2020
|
Mary L Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,336
+25.83%
|
$154,176
$66.35 P/Share
|
|
Nov 18
2020
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,408
+3.03%
|
$290,928
$66.35 P/Share
|
|
Nov 18
2020
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,752
+6.91%
|
$115,632
$66.35 P/Share
|
|
Nov 18
2020
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,836
+8.18%
|
$121,176
$66.35 P/Share
|
|
Nov 13
2020
|
Alan Lotvin EVP&President-PharmacyServices |
SELL
Open market or private sale
|
Direct |
7,138
-47.08%
|
$499,660
$70.0 P/Share
|
|
Nov 10
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
SELL
Open market or private sale
|
Direct |
21,460
-46.19%
|
$1,502,200
$70.0 P/Share
|
|
Nov 10
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
BUY
Exercise of conversion of derivative security
|
Direct |
21,460
+31.6%
|
$729,640
$34.96 P/Share
|